Abstract
Leukocyte migration inhibition tests (LMIT) were performed to measure the immunologic reactivity of patients with initially operable breast cancer. Leukocyte migration was inhibited in 38% of 159 patients in the presence of autologous tumor extract, in 33% of 160 subjects in the presence of autologous serum, and in 47% of 148 patients in the presence of extract and serum. These patients formed part of a randomized clinical trial comparing conventional treatment complemented by injections of poly A · poly U with conventional treatment and injection of saline as a placebo.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
